Thomas F. Pack

772 total citations
17 papers, 556 citations indexed

About

Thomas F. Pack is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas F. Pack has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas F. Pack's work include Receptor Mechanisms and Signaling (13 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Thomas F. Pack is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Thomas F. Pack collaborates with scholars based in United States, Japan and United Kingdom. Thomas F. Pack's co-authors include Marc G. Caron, Sean M. Peterson, Jeffrey S. Smith, Nikhil M. Urs, Joshua C. Snyder, Emiliana Borrelli, Asuka Inoue, Sudarshan Rajagopal, Caroline E. Bass and Olivier Lichtarge and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas F. Pack

17 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas F. Pack United States 13 380 238 91 63 51 17 556
Shu Z. Wiley United States 8 344 0.9× 99 0.4× 79 0.9× 39 0.6× 33 0.6× 10 454
Wayne Stallaert United States 11 367 1.0× 184 0.8× 62 0.7× 24 0.4× 24 0.5× 16 481
Thierry Métayé France 13 351 0.9× 118 0.5× 70 0.8× 129 2.0× 28 0.5× 22 616
Élodie Archer-Lahlou Canada 10 304 0.8× 240 1.0× 79 0.9× 17 0.3× 16 0.3× 12 435
Jialu Wang China 13 628 1.7× 231 1.0× 48 0.5× 35 0.6× 36 0.7× 25 830
Kyle Hurth United States 13 182 0.5× 71 0.3× 59 0.6× 61 1.0× 29 0.6× 46 599
George Vaniotis Canada 10 463 1.2× 180 0.8× 64 0.7× 23 0.4× 33 0.6× 12 614
Kim Jonas United Kingdom 17 439 1.2× 203 0.9× 53 0.6× 15 0.2× 41 0.8× 30 718
Ricardo Hermosilla Germany 16 564 1.5× 180 0.8× 47 0.5× 123 2.0× 68 1.3× 24 768
Wanjing Guo China 4 345 0.9× 189 0.8× 31 0.3× 17 0.3× 26 0.5× 6 429

Countries citing papers authored by Thomas F. Pack

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Pack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Pack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Pack more than expected).

Fields of papers citing papers by Thomas F. Pack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Pack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Pack. The network helps show where Thomas F. Pack may publish in the future.

Co-authorship network of co-authors of Thomas F. Pack

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Pack. A scholar is included among the top collaborators of Thomas F. Pack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Pack. Thomas F. Pack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
MacLean, Margaret R., et al.. (2022). Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho. Comprehensive physiology. 12(4). 4103–4118. 13 indexed citations
2.
MacLean, Margaret R., et al.. (2022). Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho. Comprehensive physiology. 12(4). 4103–4118. 2 indexed citations
3.
Smith, Jeffrey S., Dylan Scott Eiger, Anmol Warman, et al.. (2022). Biased agonists of the chemokine receptor CXCR3 differentially signal through Gα i :β-arrestin complexes. Science Signaling. 15(726). eabg5203–eabg5203. 12 indexed citations
4.
Smith, Jeffrey S., Thomas F. Pack, Asuka Inoue, et al.. (2021). Noncanonical scaffolding of G αi and β-arrestin by G protein–coupled receptors. Science. 371(6534). 73 indexed citations
5.
Smith, Jeffrey S. & Thomas F. Pack. (2021). Noncanonical interactions of G proteins and β‐arrestins: from competitors to companions. FEBS Journal. 288(8). 2550–2561. 10 indexed citations
6.
Smith, Jeffrey S., Rogan Rattray, Mary L. Campbell, et al.. (2020). Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity. SHILAP Revista de lepidopterología. 5(1). 59 indexed citations
8.
Pack, Thomas F., et al.. (2018). The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation. Journal of Biological Chemistry. 293(16). 6161–6171. 37 indexed citations
9.
Tóth, Krisztián, Lauren M. Slosky, Thomas F. Pack, et al.. (2017). Ghrelin receptor antagonism of hyperlocomotion in cocaine‐sensitized mice requires βarrestin‐2. Synapse. 72(1). 13 indexed citations
10.
Snyder, Joshua C., Lauren K. Rochelle, Thomas F. Pack, et al.. (2017). Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness. Journal of Biological Chemistry. 292(17). 7208–7222. 18 indexed citations
11.
Pack, Thomas F., et al.. (2017). Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions. Neuropsychopharmacology. 43(5). 1164–1173. 25 indexed citations
12.
Smith, Jeffrey S., Priya Alagesan, Thomas F. Pack, et al.. (2017). C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways. Molecular Pharmacology. 92(2). 136–150. 49 indexed citations
13.
Urs, Nikhil M., Steven M. Gee, Thomas F. Pack, et al.. (2016). Distinct cortical and striatal actions of a β-arrestin–biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. Proceedings of the National Academy of Sciences. 113(50). E8178–E8186. 107 indexed citations
14.
Peterson, Sean M., Thomas F. Pack, & Marc G. Caron. (2015). Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity. PLoS ONE. 10(10). e0141637–e0141637. 20 indexed citations
15.
Snyder, Joshua C., Thomas F. Pack, Lauren K. Rochelle, et al.. (2015). A rapid and affordable screening platform for membrane protein trafficking. BMC Biology. 13(1). 107–107. 20 indexed citations
16.
Peterson, Sean M., Thomas F. Pack, Angela D. Wilkins, et al.. (2015). Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor. Proceedings of the National Academy of Sciences. 112(22). 7097–7102. 74 indexed citations
17.
Peng, Can, Matthew R. Kimbrell, Thomas F. Pack, et al.. (2013). Multiple Modes of α7 nAChR Noncompetitive Antagonism of Control Agonist-Evoked and Allosterically Enhanced Currents. Molecular Pharmacology. 84(3). 459–475. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026